SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GuyNixon who wrote (458)8/18/1997 9:45:00 AM
From: Henry Niman   of 2173
 
Guy, I'm not a trader, so don't ask me. I expect the JNJ collaboration to continue since they have already seen interim data and I suspect that some of the subsequent Phase III trials were designed to isolate a target population. I expect the price (which has set a 52-week low of 8 3/8) to still show a good deal of bouncing today.

Henry

While writing this post, AMLN set a 52-week low of 8 1/8 and has already bounced to 9 5/8. Volume is about 1/2 million.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News